{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"70.8","upperLimit":"81.9","value":"76.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"240"}],"units":"Participants"}],"description":"CRR is defined as the percentage of patients who achieved a complete response (CR) at the 3-month Visit. A patient was considered a CR if there was no detectable disease in the bladder based on visual observation (white light cystoscopy), biopsy of remaining lesions (if applicable), and voiding urine cytology.","dispersionType":"95% Confidence Interval","groups":[{"description":"6 once-weekly intravesical instillations of UGN-102 (75 mg mitomycin).","id":"OG000","title":"UGN-102"}],"paramType":"NUMBER","populationDescription":"All patients who received any dose of UGN-102.","reportingStatus":"POSTED","timeFrame":"3 months","title":"Complete Response Rate (CRR)","type":"PRIMARY","unitOfMeasure":"percentage of participants"}